| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.2 | 4e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.067 | 0.1 |